Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Graft-vs-Host Disease

Known as: Diseases, Graft-vs-Host, Homologous Wasting Disease, Runt Disease 
A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria for diagnosing and scoring the severity… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Mature donor T cells cause graft-versus-host disease (GVHD), but they are also the main mediators of the beneficial graft-versus… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The potential benefits of unrelated donor marrow transplantation are offset by the immunologic complications of graft-versus-host… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Acute graft-versus-host disease (aGVHD) is still a major obstacle in clinical allogeneic bone marrow (BM) transplantation. CD4… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Toxicities have limited the use of allogeneic hematopoietic cell transplantation (HCT) to younger, medically fit patients. In a… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Since allogeneic stem-cell transplantation can induce curative graft-versus-leukemia reactions in patients with… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Graft versus host disease, an alloimmune attack on host tissues mounted by donor T cells, is the most important toxicity of… Expand
Is this relevant?
Highly Cited
1981
Highly Cited
1981
ALLOGENEIC marrow transplantation is being used with increasing frequency in the treatment of acute leukemia.1 2 3 4 Recurrent… Expand
  • figure 1
  • table 1
  • table 1
Is this relevant?
Highly Cited
1979
Highly Cited
1979
To determine whether allogeneic bone-marrow transplantation is associated with a graft-versus-leukemia effect, we examined the… Expand
Is this relevant?
Highly Cited
1974
Highly Cited
1974
Sixty-one evaluable patients, 19 with advanced aplastic anemia and 42 with end stage hematological malignancies, were conditioned… Expand
Is this relevant?